Keyphrases
Bronchiectasis
100%
Scotland
67%
Heart Failure
58%
Type 2 Diabetes Mellitus (T2DM)
52%
Confidence Interval
48%
Meta-analysis
43%
COVID-19
41%
Randomized Controlled Trial
38%
Patients with Heart Failure
36%
Diabetes
33%
Scottish
29%
Clinical Trials
28%
Tayside
28%
Primary Ciliary Dyskinesia
27%
Heart Failure with Preserved Ejection Fraction (HFpEF)
27%
Hazard Ratio
26%
Genome-wide Association Study
26%
Asthma
25%
Placebo
25%
Risk Factors
24%
Coronary Artery Disease
23%
Hepatitis C
22%
Hospitalization
22%
Inflammatory Bowel Disease
22%
Clinical Outcomes
22%
Chronic Obstructive Pulmonary Disease
21%
Cardiovascular Disease
21%
Type 1 Diabetes Mellitus (T1DM)
21%
All-cause Mortality
20%
Primary Care
20%
Metformin
20%
Inhaled Corticosteroids
20%
Crohn's Disease
19%
Systematic Meta-analysis
19%
Hepatitis C Virus
18%
Inflammation
18%
Blood Pressure
18%
Odds Ratio
18%
Quality of Life
17%
Cardiovascular Risk
17%
United Kingdom
17%
People Who Inject Drugs
16%
Europe
16%
High Risk
16%
Hypertension
15%
Type I Diabetes
15%
Older People
15%
Comorbidity
15%
Airway
14%
Chronic Heart Failure
14%
Hospital Admission
14%
Patients with Diabetes
14%
European Respiratory Society
14%
Cutaneous Squamous Cell Carcinoma (cSCC)
13%
Beta-blockers
13%
BIOSTAT-CHF
13%
Cardiovascular Mortality
13%
Myocardial Infarction
12%
COVID-19 Pandemic
12%
Hemoglobin A1c (HbA1c)
12%
Disease Severity
12%
Tumor
11%
Parkinson's Disease
11%
Forced Expiratory Volume in 1 Second (FEV1)
11%
Peripheral Arterial Disease
11%
Attention Deficit Hyperactivity Disorder
11%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Obesity
11%
Sputum
11%
Liver Disease
10%
Angiotensin-converting Enzyme Inhibitor (ACEi)
10%
Clinical Practice
10%
Atrial Fibrillation
10%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
10%
Community-acquired Pneumonia
10%
Breast Cancer
10%
Community Pharmacy
10%
Randomized Trial
10%
Hepatitis C Treatment
10%
Body Mass Index
10%
Genotype
10%
Older Adults
10%
Microbiome
10%
Cardiovascular Outcomes
10%
Multicenter Cohort Study
9%
Type 2 Diabetic Patients
9%
Left Ventricular Hypertrophy
9%
Randomized Placebo-controlled Trial
9%
Atopic Dermatitis
9%
Physical Activity
9%
Adverse Events
9%
Magnetic Resonance Imaging
9%
Computed Tomography
9%
Lung
9%
Allopurinol
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Statins
8%
Cost-effectiveness
8%
Lung Function
8%
Pathophysiology
8%
Medicine and Dentistry
Bronchiectasis
71%
Congestive Heart Failure
66%
Diseases
62%
COVID-19
49%
Randomized Controlled Trial
42%
Diabetes
40%
Maturity Onset Diabetes of the Young
34%
Systematic Review
34%
Biological Marker
31%
Cardiovascular Disease
28%
Cohort Analysis
26%
Chronic Obstructive Pulmonary Disease
26%
Placebo
24%
Clinical Trial
24%
Cardiovascular System
24%
Malignant Neoplasm
24%
Meta-Analysis
23%
Asthma
22%
Hepatitis C
22%
Quality of Life
21%
Prevalence
21%
Infection
20%
Primary Health Care
19%
Lung
19%
Inflammatory Bowel Disease
18%
Primary Ciliary Dyskinesia
17%
Neoplasm
17%
Clinician
16%
Health Care Cost
16%
Hepatitis C Virus
16%
Hazard Ratio
15%
Liver Disease
14%
Pediatrics
14%
Observational Study
13%
Medicine
13%
Magnetic Resonance Imaging
13%
Crohn's Disease
12%
Sputum
12%
Adverse Event
12%
Ejection Fraction
11%
Cardiovascular Risk
11%
Glycon
11%
Myocardial Infarction
11%
Skin Carcinoma
11%
Insulin Dependent Diabetes Mellitus
11%
Blood Pressure
11%
Heart Failure with Reduced Ejection Fraction
11%
Arm
11%
Odds Ratio
11%
Breast Cancer
11%
Cardiac Magnetic Resonance Imaging
10%
Microbiome
10%
Coronary Artery Disease
10%
Community-Acquired Pneumonia
10%
Cystic Fibrosis
10%
Cancer
10%
Antibiotics
9%
Ischemic Heart Disease
9%
Gene Linkage
9%
Comorbidity
9%
Atopic Dermatitis
9%
Liver Cirrhosis
9%
Body Mass Index
8%
Apoplexy
8%
Public Health
8%
Photochemotherapy
8%
Heart Failure with Preserved Ejection Fraction
8%
Arteriosclerosis Obliterans
8%
Respiratory Tract Infection
8%
ACE Inhibitor
8%
Cost-Effectiveness Analysis
8%
Patient Referral
7%
Pathophysiology
7%
Heart Ventricle Remodeling
7%
Skin Cancer
7%
Hemoglobin A1c
7%
Retrospective Study
7%
Genome Wide Association Study
7%
Nonalcoholic Fatty Liver
7%
Neutrophil
7%
Oscillometry
7%
Left Ventricular Hypertrophy
7%
Diabetes Mellitus
7%
Sarcopenia
7%
Disease Severity
7%
Disease
6%
Respiratory Disease
6%
Chronic Kidney Disease
6%
Endotype
6%
Volunteer
6%
All Cause Mortality
6%
Colorectal Carcinoma
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
National Health Service
6%
Hypoglycemia
6%
Prospective Cohort Study
6%
Pseudomonas aeruginosa
6%
Secondary Care
6%
Phototherapy
6%
Computer Assisted Tomography
6%